Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Abliva Net Income (Quarterly): -2.377M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.377M |
| September 30, 2023 | -3.055M |
| June 30, 2023 | -2.020M |
| March 31, 2023 | -1.544M |
| December 31, 2022 | -1.646M |
| September 30, 2022 | -2.396M |
| June 30, 2022 | -2.099M |
| March 31, 2022 | -2.365M |
| December 31, 2021 | -4.175M |
| September 30, 2021 | -4.036M |
| June 30, 2021 | -3.606M |
| March 31, 2021 | -2.562M |
| December 31, 2020 | -1.519M |
| September 30, 2020 | -1.138M |
| June 30, 2020 | -2.101M |
| March 31, 2020 | -1.720M |
| December 31, 2019 | -2.823M |
| September 30, 2019 | -1.596M |
| June 30, 2019 | -2.199M |
| March 31, 2019 | -1.509M |
| December 31, 2018 | -1.642M |
| September 30, 2018 | -1.675M |
| June 30, 2018 | -2.944M |
| March 31, 2018 | -1.611M |
| December 31, 2017 | -1.776M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.612M |
| June 30, 2017 | -2.528M |
| March 31, 2017 | -1.859M |
| December 31, 2016 | -1.435M |
| September 30, 2016 | -4.025M |
| June 30, 2016 | -1.411M |
| March 31, 2016 | -1.253M |
| December 31, 2015 | -0.802M |
| September 30, 2015 | -6.322M |
| June 30, 2015 | -1.855M |
| March 31, 2015 | -1.685M |
| December 31, 2014 | -2.195M |
| September 30, 2014 | -0.497M |
| June 30, 2014 | -2.005M |
| March 31, 2014 | -1.481M |
| December 31, 2013 | -1.312M |
| September 30, 2013 | -0.9782M |
| June 30, 2013 | -0.4376M |
| March 31, 2013 | -0.7034M |
| December 31, 2012 | -0.711M |
| September 30, 2012 | -0.5456M |
| June 30, 2012 | -0.5545M |
| March 31, 2012 | -0.3881M |
| December 31, 2011 | -0.3911M |
| September 30, 2011 | -0.3603M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.175M
Minimum
Dec 2021
-1.138M
Maximum
Sep 2020
-2.367M
Average
-2.199M
Median
Jun 2019
Net Income (Quarterly) Benchmarks
| Karolinska Development AB | 0.0201M |
| Calliditas Therapeutics AB | -1.730M |
| Oncopeptides AB | -3.758M |
| Olink Holding AB | -16.06M |
| BioInvent International AB | -7.515M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0129M |
| Total Expenses (Quarterly) | 2.598M |
| EPS Diluted (Quarterly) | -0.0019 |
| Enterprise Value | 7.716M |
| Profit Margin (Quarterly) | -18.42K% |
| Earnings Yield | -84.88% |
| Normalized Earnings Yield | -84.91 |